The top 20 pathways (p < 0.05; Figure 4C) showed that GS-Rd intervention on AD targets involves multiple signaling pathways, including MAPK (mitogen-activated protein kinase) signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway and FOXO signaling pathway. The gene discussed is WNK2; the disease is Alzheimer disease.